Covered recipient · General Payments record
RANDALL E HENDERSON
Allopathic & Osteopathic Physicians Anesthesiology
General Payments · PY2018–2024
$3,891.09
- Reported across 113 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $676.02 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $310.25 | 20 |
| Phathom Pharmaceuticals, Inc. | $125.00 | 1 |
| Regeneron Healthcare Solutions, Inc. | $121.36 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $99.12 | 4 |
| Actelion Pharmaceuticals US, Inc. | $20.29 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.67 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103903898 | CMS |
| ABBVIE INC. | $14.19 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103903900 | CMS |
| ABBVIE INC. | $20.39 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103903902 | CMS |
| ABBVIE INC. | $14.56 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103903904 | CMS |
| ABBVIE INC. | $17.26 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103903906 | CMS |
| ABBVIE INC. | $19.68 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103903908 | CMS |
| ABBVIE INC. | $2.43 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103903910 | CMS |
| ABBVIE INC. | $16.79 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103903912 | CMS |
| ABBVIE INC. | $17.49 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103903914 | CMS |
| ABBVIE INC. | $17.73 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103903916 | CMS |
| ABBVIE INC. | $15.36 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103903918 | CMS |
| ABBVIE INC. | $1.68 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103903920 | CMS |
| ABBVIE INC. | $21.30 | 06/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103903922 | CMS |
| ABBVIE INC. | $18.58 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103903924 | CMS |
| ABBVIE INC. | $23.76 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103903926 | CMS |
| ABBVIE INC. | $2.24 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103903928 | CMS |
| ABBVIE INC. | $13.64 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103903930 | CMS |
| ABBVIE INC. | $15.49 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103903932 | CMS |
| ABBVIE INC. | $18.18 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103903934 | CMS |
| ABBVIE INC. | $19.83 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103903936 | CMS |
| Actelion Pharmaceuticals US, Inc. | $20.29 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078907709 | CMS |
| Phathom Pharmaceuticals, Inc. | $125.00 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151071476 | CMS |
| Regeneron Healthcare Solutions, Inc. | $121.36 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114067927 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $29.40 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137574452 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $22.54 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137574455 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $19.31 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137574459 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $27.87 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137574463 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.